GlySens Incorporated was founded in 1998 by David A. Gough and Joseph Lucisano, a bioengineering graduate at the University of California, San Diego.
Additionally, is an external receiver used to display glucose readings and patterns in real-time, hoping to help reduce the level of care needed in diabetics.
Lucisano, GlySens Chief Technology Officer, announced that in a future iteration the receiver should be converted to a software application that can run on a cell phone.
[citation needed] Science Translational Medicine reported success on long-term glucose monitoring with the sensor-telemetry system implanted in the tissues of pigs.
[5] The long-term animal results reported by David Gough provide a foundation for human trials, which began in January 2015 and are expected to conclude in early 2016.